vs
Side-by-side financial comparison of Agilent Technologies (A) and ICON PLC (ICLR). Click either name above to swap in a different company.
ICON PLC is the larger business by last-quarter revenue ($2.0B vs $1.8B, roughly 1.1× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 0.1%, a 16.8% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs 0.6%). ICON PLC produced more free cash flow last quarter ($333.9M vs $175.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs 0.6%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.
A vs ICLR — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.0B |
| Net Profit | $305.0M | $2.4M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 4.2% |
| Net Margin | 17.0% | 0.1% |
| Revenue YoY | 7.0% | 0.6% |
| Net Profit YoY | -4.1% | -98.8% |
| EPS (diluted) | $1.07 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.7B | $2.0B | ||
| Q1 25 | $1.7B | $2.0B | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $2.1B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | — | ||
| Q3 25 | $336.0M | $2.4M | ||
| Q2 25 | $215.0M | $183.0M | ||
| Q1 25 | $318.0M | $154.2M | ||
| Q4 24 | $351.0M | — | ||
| Q3 24 | $282.0M | $197.1M | ||
| Q2 24 | $308.0M | $146.9M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 20.7% | 4.2% | ||
| Q2 25 | 18.0% | 10.4% | ||
| Q1 25 | 22.4% | 11.0% | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 21.1% | 14.1% | ||
| Q2 24 | 23.1% | 10.8% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | — | ||
| Q3 25 | 19.3% | 0.1% | ||
| Q2 25 | 12.9% | 9.1% | ||
| Q1 25 | 18.9% | 7.7% | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 17.9% | 9.7% | ||
| Q2 24 | 19.6% | 6.9% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | — | ||
| Q3 25 | $1.18 | $0.03 | ||
| Q2 25 | $0.75 | $2.30 | ||
| Q1 25 | $1.11 | $1.90 | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $0.97 | $2.36 | ||
| Q2 24 | $1.05 | $1.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $468.9M |
| Total DebtLower is stronger | $3.0B | — |
| Stockholders' EquityBook value | $6.9B | $9.3B |
| Total Assets | $12.8B | $16.5B |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | $468.9M | ||
| Q2 25 | $1.5B | $390.4M | ||
| Q1 25 | $1.5B | $526.7M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | $695.5M | ||
| Q2 24 | $1.7B | $506.6M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | — | ||
| Q3 25 | $6.4B | $9.3B | ||
| Q2 25 | $6.1B | $9.6B | ||
| Q1 25 | $6.0B | $9.5B | ||
| Q4 24 | $5.9B | — | ||
| Q3 24 | $5.9B | $9.8B | ||
| Q2 24 | $6.2B | $9.6B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | — | ||
| Q3 25 | $12.2B | $16.5B | ||
| Q2 25 | $12.2B | $16.6B | ||
| Q1 25 | $11.9B | $16.7B | ||
| Q4 24 | $11.8B | — | ||
| Q3 24 | $11.0B | $17.2B | ||
| Q2 24 | $10.9B | $17.0B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $387.6M |
| Free Cash FlowOCF − Capex | $175.0M | $333.9M |
| FCF MarginFCF / Revenue | 9.7% | 16.3% |
| Capex IntensityCapex / Revenue | 5.2% | 2.6% |
| Cash ConversionOCF / Net Profit | 0.88× | 164.59× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | — | ||
| Q3 25 | $362.0M | $387.6M | ||
| Q2 25 | $221.0M | $146.2M | ||
| Q1 25 | $431.0M | $268.2M | ||
| Q4 24 | $481.0M | — | ||
| Q3 24 | $452.0M | $402.7M | ||
| Q2 24 | $333.0M | $218.6M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | $333.9M | ||
| Q2 25 | $107.0M | $113.9M | ||
| Q1 25 | $334.0M | $239.3M | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | $359.3M | ||
| Q2 24 | $230.0M | $182.3M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | 16.3% | ||
| Q2 25 | 6.4% | 5.6% | ||
| Q1 25 | 19.9% | 12.0% | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | 17.7% | ||
| Q2 24 | 14.6% | 8.6% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | 2.6% | ||
| Q2 25 | 6.8% | 1.6% | ||
| Q1 25 | 5.8% | 1.4% | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | 2.1% | ||
| Q2 24 | 6.5% | 1.7% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | 164.59× | ||
| Q2 25 | 1.03× | 0.80× | ||
| Q1 25 | 1.36× | 1.74× | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | 2.04× | ||
| Q2 24 | 1.08× | 1.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ICLR
| Other Customers | $681.3M | 33% |
| Clients1125 | $549.4M | 27% |
| Clients15 | $503.3M | 25% |
| Clients610 | $308.8M | 15% |
